Development Level

Tbio 4 | 10,625
Tclin 2 | 602
Tchem 1 | 1,890

Disease

Cancer 5 | 2,346
psoriasis 5 | 6,685
Breast cancer 4 | 3,094
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,956
non-small cell lung cancer 4 | 2,798
head and neck cancer and chronic obstructive pulmonary disease 3 | 237
interstitial cystitis 3 | 2,299
osteosarcoma 3 | 7,933
ovarian cancer 3 | 8,484
pancreatic cancer 3 | 2,300
Hypersensitivity reaction type II disease 2 | 235
Liver carcinoma 2 | 217
Rheumatoid Arthritis 2 | 1,160
atypical teratoid / rhabdoid tumor 2 | 4,369
colon cancer 2 | 1,475
cutaneous lupus erythematosus 2 | 1,056
cystic fibrosis 2 | 1,665
glioblastoma 2 | 5,572
group 3 medulloblastoma 2 | 2,254
invasive ductal carcinoma 2 | 2,950
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
oligodendroglioma 2 | 2,849
pediatric high grade glioma 2 | 2,712
primary pancreatic ductal adenocarcinoma 2 | 1,271
primitive neuroectodermal tumor 2 | 3,031
sarcoidosis 2 | 358
subependymal giant cell astrocytoma 2 | 2,287
tuberculosis 2 | 1,557
ulcerative colitis 2 | 2,087
Alcoholic Intoxication, Chronic 1 | 41
Alzheimer's disease 1 | 644
Amphetamine-Related Disorders 1 | 74
Amyotrophic Lateral Sclerosis 1 | 431
Anoxia 1 | 33
Arthritis 1 | 248
Atopic dermatitis 1 | 944
Autistic Disorder 1 | 320
Balkan Nephropathy 1 | 6
Brain disease 1 | 83
COPD 1 | 113
Cocaine-Related Disorders 1 | 88
Dementia 1 | 129
Endometriosis 1 | 535
Gaucher's disease 1 | 24
Gout 1 | 93
Hepatitis B 1 | 103
Hepatolenticular Degeneration 1 | 24
Huntington's disease 1 | 72
Hypersensitivity 1 | 63
IGA Glomerulonephritis 1 | 454
Juvenile rheumatoid arthritis 1 | 104
Lewy Body Disease 1 | 19
Lupus erythematosus 1 | 80
Manganese Poisoning 1 | 11
Multiple Sclerosis 1 | 498
Multiple system atrophy 1 | 27
Nerve Degeneration 1 | 73
Neurodegenerative Disorders 1 | 37
Neurodegenerative disease 1 | 383
Olivopontocerebellar atrophy 1 | 9
Optic atrophy 1 | 43
Oxyphilic adenoma 1 | 21
Pantothenate kinase-associated neurodegeneration 1 | 15
Parkinson Disease 1 | 102
Parkinson's disease 1 | 364
Parkinsonian Disorders 1 | 23
Pick disease 1 | 1,893
Pick's disease 1 | 14
Psychoses, Substance-Induced 1 | 17
Pulmonary hypertension 1 | 52
REM sleep behavior disorder 1 | 16
Substance-Related Disorders 1 | 114
Toxic encephalopathy 1 | 131
Transitional cell carcinoma 1 | 18
Tularemia 1 | 22
Vaccinia 1 | 37
active Crohn's disease 1 | 918
active ulcerative colitis 1 | 477
astrocytic glioma 1 | 2,241
breast carcinoma 1 | 1,614
chronic lymphosyte leukemia 1 | 232
ependymoma 1 | 2,514
head and neck cancer 1 | 270
hepatocellular carcinoma 1 | 532
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
medulloblastoma 1 | 1,524
mucosa-associated lymphoid tissue lymphoma 1 | 480
nasopharyngeal carcinoma 1 | 1,056
non diabetic and post-ischemic heart failure 1 | 200
non-small cell lung carcinoma 1 | 413
pancreatic carcinoma 1 | 567
pilocytic astrocytoma 1 | 3,086
pituitary cancer 1 | 1,972
posterior fossa group A ependymoma 1 | 1,511
tuberculosis and treatment for 3 months 1 | 327
uncontrolled asthma 1 | 67
urothelial carcinoma 1 | 318

Tissue

Blood and immune system 7 | 17,995
Cardiovascular System 7 | 17,958
Digestive Tract 7 | 18,473
Endocrine System 7 | 18,512
Female tissues 7 | 18,647
Liver and Pancreas 7 | 18,136
Male tissues 7 | 17,969
Nervous System 7 | 18,561
Respiratory system 7 | 17,484
Skin and soft tissues 7 | 18,115
Urinary Tract 7 | 18,444

Target Family

Non-IDG 6 | 11,971
Enzyme 1 | 4,146

Grant Application

1R01CA134345-01A1 7 | 7
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Alpha-synuclein SNCA Tchem Non-IDG -3.59982 3997.3 1484
CD276 antigen CD276 Tbio Non-IDG -2.93293 733.9 392
U3 small nucleolar ribonucleoprotein protein IMP3 IMP3 Tbio Non-IDG -0.36798 1.83 129
Programmed cell death 1 ligand 1 CD274 Tclin Non-IDG -3.20982 2228.3 671
V-set domain-containing T-cell activation inhibitor 1 VTCN1 Tbio Non-IDG -2.05577 156.3 396
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Carbonic anhydrase 9 CA9 Tclin Enzyme -2.94768 948.4 621